# Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD

> clinical trial · VERIFIED · 2026-07-23

Status: NOT_YET_RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: Lymphocytic Leukemia

- Company: M.D. Anderson Cancer Center
- Sector: Lymphocytic Leukemia
- Primary source: https://clinicaltrials.gov/study/NCT07566364

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.